CRISPR Therapeutics
Startup
Summarized by Halo AI
CRISPR Therapeutics is a biotechnology company pioneering gene-based medicines using CRISPR/Cas9 gene-editing technology to develop potential cures for patients suffering from serious diseases.
Founded & HQ
Basel, Switzerland
Company size
201-500 employees
Funding
~$1B
IP status
983 patents filed · 1 grant confirmed
Activity highlights
Won a U.S. patent for CRISPR/Cas9 genome editing with Intellia and Caribou
CRISPR Therapeutics is a biotechnology company dedicated to developing gene-based medicines using CRISPR/Cas9 technology, with a focus on serious diseases like blood disorders, cancer, and autoimmune conditions.
AI summary generated on Jun 22, 2026
OpenAlex
OpenAlexFor general inquiries
NM
Nivedita Madduri
Application Specialist
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.